犬关节炎治疗市场规模、份额和成长分析（按关节炎类型、给药途径、治疗方法、最终用户和地区）- 产业预测（2025-2032）

2023 年全球犬关节炎治疗市场规模为 27 亿美元，预计将从 2024 年的 28.3 亿美元成长到 2032 年的 41.2 亿美元，预测期内（2025-2032 年）的复合年增长率为 4.8%。

全球犬关节炎治疗市场正经历强劲成长，这主要得益于骨关节炎盛行率的上升，尤其是在老化、肥胖和品种多样化的犬类中。定期体检和早期诊断的趋势尤其明显，尤其是在已开发地区，因为宠物饲主优先考虑兽医护理，以提升宠物活动能力和控制疼痛。此外，对单株抗体、非类固醇消炎剂(NSAID) 和再生药物等长期治疗药物的需求不断增长，进一步推动了市场成长。远端医疗服务和线上兽药店的扩张也提高了市场渗透率。动物用药品公司持续投入研发，市场前景更光明。总体而言，宠物医疗保健和预防性治疗支出的增加，正在推动犬关节炎治疗市场的良好成长。

目录

介绍

• 分析目的
• 市场覆盖
• 定义

分析方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与约束

执行摘要

• 市场概况与展望
• 供需趋势分析
• 按细分市场进行机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场观察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场魅力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析
• 技术进步
• 案例研究

全球犬关节炎治疗市场规模及复合年增长率（按关节炎类型划分）（2025-2032 年）

• 市场概览
• 骨关节炎
• 骨软骨病
• 类风湿性关节炎
• 创伤性关节炎

全球犬关节炎治疗市场规模及依给药途径分類的复合年增长率（2025-2032）

• 市场概览
• 口服
• 肠外
• 其他的

全球犬关节炎治疗市场规模及复合年增长率（按治疗方法）（2025-2032 年）

• 市场概览
• 非类固醇消炎剂（NSAID）
• 阿片类药物
• 干细胞疗法
• 同种异体干细胞
• 自体干细胞

全球犬关节炎治疗市场规模及最终用户复合年增长率（2025-2032）

• 市场概览
• 医院
• 专科诊所
• 其他的

全球犬关节炎治疗市场规模及依通路分類的复合年增长率（2025-2032）

• 市场概览
• 兽医诊所
• 零售药局
• 网路药局
• 其他的

犬关节炎治疗的全球市场规模和复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争格局

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要企业采取的策略
• 近期市场趋势
• 主要企业市场占有率（2024年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分析市场份额
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Boehringer Ingelheim
• Zoetis
• Elanco
• Decora Pharmaceuticals
• Merck Animal Health
• American Regent, Inc.
• Bayer AG
• Nutramax Laboratories Veterinary Sciences, Inc.
• VetStem, Inc.
• Virbac

结论和建议

Global Canine Arthritis Treatment Market size was valued at USD 2.7 billion in 2023 and is poised to grow from USD 2.83 billion in 2024 to USD 4.12 billion by 2032, growing at a CAGR of 4.8% during the forecast period (2025-2032).

The global canine arthritis treatment market is witnessing robust growth driven by the rising prevalence of osteoarthritis, particularly in aging, obese, and breed-prone dogs. Pet owners increasingly prioritize veterinary care for mobility and pain management, with a marked trend towards regular examinations and early diagnoses, especially in developed regions. This growth is further fueled by escalating demand for long-term therapeutics, including monoclonal antibodies, NSAIDs, and regenerative medicines. The expansion of telehealth services and online veterinary pharmacies is also enhancing market penetration. Consistent investments in research and development by veterinary pharmaceutical companies underline a positive market outlook. Overall, the increase in spending on pet healthcare and preventative treatments is propelling favorable growth in the canine arthritis treatment sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Canine Arthritis Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Canine Arthritis Treatment Market Segments Analysis

Global Canine Arthritis Treatment Market is segmented by Arthritis Type, Route of Administration, Treatment, End-Users, Distribution Channel and region. Based on Arthritis Type, the market is segmented into Osteoarthritis, Osteochondrosis, Rheumatoid arthritis and Traumatic arthritis. Based on Route of Administration, the market is segmented into Oral, Parenteral and Others. Based on Treatment, the market is segmented into Non-steroidal anti-inflammatory Medications (NSAIDs), Opioids, Stem Cell Therapy, Allogeneic Stem Cells and Autologous Stem Cells. Based on End-Users, the market is segmented into Hospitals, Speciality Clinics and Others. Based on Distribution Channel, the market is segmented into Veterinary Hospitals & Clinics, Retail Pharmacies, Online Pharmacies and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Canine Arthritis Treatment Market

The Global Canine Arthritis Treatment market is primarily driven by significant advancements in nutrition and veterinary medicine, which have enabled dogs to age more gracefully. As a result, there has been an increase in age-related diseases like arthritis, creating a heightened demand for wellness support and chronic care services specifically tailored for these conditions. This demographic shift highlights the growing focus on aging dogs, prompting substantial investments in treatments and medications aimed at promoting long-term joint health. Consequently, the market is evolving to meet the needs of pet owners seeking effective solutions for their canine companions suffering from arthritis.

Restraints in the Global Canine Arthritis Treatment Market

The Global Canine Arthritis Treatment market faces significant restraints due to the high costs associated with biologics and regenerative therapies, which restrict options for pet owners in low- and middle-income communities. This challenge is further exacerbated in rural areas, where there is often a shortage of veterinary specialists, making it difficult for pet owners to obtain timely diagnoses and management of these advanced therapies. These accessibility issues not only hinder the adoption of regenerative treatments but also impede the development of pet healthcare systems in emerging markets, ultimately affecting the overall growth potential of the market.

Market Trends of the Global Canine Arthritis Treatment Market

The Global Canine Arthritis Treatment market is witnessing a significant trend towards biologic and regenerative therapies, particularly monoclonal antibodies and stem cell treatments, which are leading the charge in innovative approaches. These therapies prioritize personalized care and sustainability, offering prolonged pain relief with minimal side effects, which resonates with both pet owners and veterinary professionals. This shift represents a strategic evolution in the market, emphasizing enhanced chronic care and the rapid advancement of veterinarian therapeutic solutions. As demand for more effective and less invasive treatments escalates, the market is evolving to meet these preferences, driving growth and innovation in canine arthritis management.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Analysis
• Case Studies

Global Canine Arthritis Treatment Market Size by Arthritis Type & CAGR (2025-2032)

• Market Overview
• Osteoarthritis
• Osteochondrosis
• Rheumatoid arthritis
• Traumatic arthritis

Global Canine Arthritis Treatment Market Size by Route of Administration & CAGR (2025-2032)

• Market Overview
• Oral
• Parenteral
• Others

Global Canine Arthritis Treatment Market Size by Treatment & CAGR (2025-2032)

• Market Overview
• Non-steroidal anti-inflammatory Medications (NSAIDs)
• Opioids
• Stem Cell Therapy
• Allogeneic Stem Cells
• Autologous Stem Cells

Global Canine Arthritis Treatment Market Size by End-Users & CAGR (2025-2032)

• Market Overview
• Hospitals
• Speciality Clinics
• Others

Global Canine Arthritis Treatment Market Size by Distribution Channel & CAGR (2025-2032)

• Market Overview
• Veterinary Hospitals & Clinics
• Retail Pharmacies
• Online Pharmacies
• Others

Global Canine Arthritis Treatment Market Size & CAGR (2025-2032)

• North America (Arthritis Type, Route of Administration, Treatment, End-Users, Distribution Channel)
  • US
  • Canada
• Europe (Arthritis Type, Route of Administration, Treatment, End-Users, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Arthritis Type, Route of Administration, Treatment, End-Users, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Arthritis Type, Route of Administration, Treatment, End-Users, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Arthritis Type, Route of Administration, Treatment, End-Users, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Boehringer Ingelheim
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zoetis
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elanco
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Decora Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• American Regent, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nutramax Laboratories Veterinary Sciences, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VetStem, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virbac
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations